tirzepatide b12/glycine Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity tirzepatide glycine b12 side effects

Wegovy Wegovy is another drug manufactured by Novo Nordisk that is an injectable semaglutide medication and is taken once a week like Ozempic

One study published in JAMA Network Open followed people taking different dosages of semaglutide and found that, after six months, those taking 1.7mg or 2.4mg doses had an average weight loss of 12.1% of their starting weight while those taking lower doses of 1mg or less lost an average of 9.2% of their weight

10.1002/art.25017 10

For weight management, semaglutide treatment should be part of a physician-guided program that may include nutrition education, physical activity guidance, medical monitoring, and follow-up care